1. Home
  2. OBIO vs CBNK Comparison

OBIO vs CBNK Comparison

Compare OBIO & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • CBNK
  • Stock Information
  • Founded
  • OBIO 2017
  • CBNK 1974
  • Country
  • OBIO United States
  • CBNK United States
  • Employees
  • OBIO N/A
  • CBNK N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • CBNK Major Banks
  • Sector
  • OBIO Health Care
  • CBNK Finance
  • Exchange
  • OBIO Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • OBIO 118.8M
  • CBNK 517.6M
  • IPO Year
  • OBIO N/A
  • CBNK 2018
  • Fundamental
  • Price
  • OBIO $2.96
  • CBNK $34.75
  • Analyst Decision
  • OBIO Strong Buy
  • CBNK Hold
  • Analyst Count
  • OBIO 5
  • CBNK 1
  • Target Price
  • OBIO $14.20
  • CBNK $35.00
  • AVG Volume (30 Days)
  • OBIO 369.8K
  • CBNK 82.9K
  • Earning Date
  • OBIO 08-11-2025
  • CBNK 07-21-2025
  • Dividend Yield
  • OBIO N/A
  • CBNK 1.13%
  • EPS Growth
  • OBIO N/A
  • CBNK 6.54
  • EPS
  • OBIO N/A
  • CBNK 2.49
  • Revenue
  • OBIO $2,886,000.00
  • CBNK $188,910,000.00
  • Revenue This Year
  • OBIO $20.47
  • CBNK $46.92
  • Revenue Next Year
  • OBIO $11.45
  • CBNK $7.82
  • P/E Ratio
  • OBIO N/A
  • CBNK $13.94
  • Revenue Growth
  • OBIO 30.23
  • CBNK 20.92
  • 52 Week Low
  • OBIO $2.37
  • CBNK $20.65
  • 52 Week High
  • OBIO $8.87
  • CBNK $35.71
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 51.30
  • CBNK 63.16
  • Support Level
  • OBIO $2.78
  • CBNK $34.96
  • Resistance Level
  • OBIO $2.94
  • CBNK $35.63
  • Average True Range (ATR)
  • OBIO 0.21
  • CBNK 0.73
  • MACD
  • OBIO -0.00
  • CBNK 0.16
  • Stochastic Oscillator
  • OBIO 60.87
  • CBNK 78.13

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: